LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate

LEO Pharma and both Oneness Biotech and Microbio Shanghai see great potential in FB825 … MBS is specialized in research and development into nucleic acid medicines and microbiome via its unique …
( read original story …)

---